ICOSAVAX, INC. Operating Expenses
ICOSAVAX, INC. reported Operating Expenses of $25.27 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-11-14
- ICOSAVAX, INC. operating expenses for the quarter ending 2023-09-30 was $25.27M, a 9.21% increase year-over-year.
- ICOSAVAX, INC. operating expenses for the quarter ending 2023-06-30 was $28.95M, a 25.18% increase year-over-year.
- ICOSAVAX, INC. operating expenses for the quarter ending 2023-03-31 was $26.52M, a 9.44% increase year-over-year.
- ICOSAVAX, INC. operating expenses for the quarter ending 2022-12-31 was $25.13M, a 23.91% increase year-over-year.
- ICOSAVAX, INC. operating expenses for fiscal 2022 was $95.64M, a 29.83% increase from fiscal 2021.
- ICOSAVAX, INC. operating expenses for fiscal 2021 was $73.66M, a 262.41% increase from fiscal 2020.
- ICOSAVAX, INC. operating expenses for fiscal 2020 was $20.33M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-09-30 | $25.27M 10-Q · filed 2023-11-14 | $54.23M derived: sum of 2 quarters · filed 2023-11-14 | $80.75M 10-Q · filed 2023-11-14 | $105.88M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $28.95M 10-Q · filed 2023-08-14 | $55.48M 10-Q · filed 2023-08-14 | $80.61M derived: sum of 3 quarters · filed 2023-08-14 | $103.75M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $26.52M 10-Q · filed 2023-05-10 | $51.65M derived: sum of 2 quarters · filed 2023-05-10 | $74.80M derived: sum of 3 quarters · filed 2023-11-14 | $97.93M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $25.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $48.27M derived: sum of 2 quarters · filed 2023-11-14 | $71.41M derived: sum of 3 quarters · filed 2023-11-14 | $95.64M 10-K · filed 2023-03-30 |
| 2022-09-30 | $23.14M 10-Q · filed 2023-11-14 | $46.27M derived: sum of 2 quarters · filed 2023-11-14 | $70.51M 10-Q · filed 2023-11-14 | $90.79M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $23.13M 10-Q · filed 2023-08-14 | $47.37M 10-Q · filed 2023-08-14 | $67.65M derived: sum of 3 quarters · filed 2023-08-14 | $103.89M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $24.23M 10-Q · filed 2023-05-10 | $44.52M derived: sum of 2 quarters · filed 2023-05-10 | $80.76M derived: sum of 3 quarters · filed 2023-05-10 | $91.25M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $20.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $56.52M derived: sum of 2 quarters · filed 2023-03-30 | $67.02M derived: sum of 3 quarters · filed 2023-03-30 | $73.66M 10-K · filed 2023-03-30 |
| 2021-09-30 | $36.24M 10-Q · filed 2022-11-14 | $46.74M derived: sum of 2 quarters · filed 2022-11-14 | $53.38M 10-Q · filed 2022-11-14 | $59.51M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $10.50M 10-Q · filed 2022-08-15 | $17.14M 10-Q · filed 2022-08-15 | $23.27M derived: sum of 3 quarters · filed 2022-08-15 | $28.73M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $6.64M 10-Q · filed 2022-05-16 | $12.78M derived: sum of 2 quarters · filed 2022-05-16 | $18.23M derived: sum of 3 quarters · filed 2022-05-16 | $23.44M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $11.59M derived: sum of 2 quarters · filed 2022-03-30 | $16.79M derived: sum of 3 quarters · filed 2022-03-30 | $20.33M 10-K · filed 2022-03-30 |
| 2020-09-30 | $5.46M 10-Q · filed 2021-11-15 | $10.66M derived: sum of 2 quarters · filed 2021-11-15 | $14.20M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $5.21M 10-Q · filed 2021-09-13 | $8.74M 10-Q · filed 2021-09-13 |